T1D | Dr. Shideh Majidi | Evolving Landscape of Type 1 Diabetes

According to the World Health Organization (WHO), social determinants of health (SDOH) are defined as the circumstances in which humans are born, develop, live, earn, and age. They are non-medical factors that influence health outcomes. The
distribution of money, power, and resources shapes these circumstances1. These socioeconomic variables contribute to societal stratification and health disparities among persons of different social and economic classes, genders, and ethnicity.

In this episode our MSL co-hosts Shweta Kulkarni, PhD and Mary Voelmle NP, CDCES have a conversation with Shideh Majidi, MD on how the landscape and incidence of T1D diagnosis and treatment is changing. Dr. Majidi identifies key barriers and attitudes that physicians and other healthcare providers may encounter when discussing screening for type 1 diabetes, particularly among patients from under resourced communities with unique challenges that are encountered daily. We conclude the episode with concrete actions and resources our listeners can use to begin to narrow the gap on healthcare disparities within under resourced communities when approaching patients and their families on education on the incidence of T1D and the option to potentially screen for T1D.

Supporting literature from episode:
1. Felicia Hill-Briggs et al. Social Determinants of Health and Diabetes: A Scientific Review. Diabetes Care 1 January 2021; 44 (1): 258–279. https://doi.org/10.2337/dci20-0053.
2. Chelak K, Chakole S. The Role of Social Determinants of Health in Promoting Health Equality: A Narrative Review. Cureus. 2023 Jan 5;15(1):e33425. doi:10.7759/cureus.33425. PMID:36751221; PMCID: PMC9899154.
3. T1D Exchange Quality Improvement Collaborative; Driving Equity and Innovation in the T1D Exchange Quality Improvement Collaborative: Advancing Outcomes Through Collaborative Change. https://doi.org/10.2337/cd23-0070.
4. Alkhatib EH, Majidi S. et al. Feasibility of caregiver diabetes distress screening in routine clinical care of youth with type 1 diabetes. Diabet Med. 2024; 00:e15416. doi:10.1111/dme.15416.
5. Divers J, et al. MMWR Morb Mortal Wkly Rep. 2020; 69(6):161-165.
6. Majidi S, et al. T1D Exchange Quality Improvement Collaborative Study Group. Inequities in Health Outcomes in Children and Adults With Type 1 Diabetes: Data From the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2021 Jul;39(3):278-283. doi: 10.2337/cd21-0028. PMID: 34421203; PMCID: PMC8329009.
7. Moshe Phillip, Linda A. DiMeglio et al.; Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes. Diabetes Care 25 July 2024; 47 (8): 1276–1298. https://doi.org/10.2337/dci24-0042.

Music: Spark of Inspiration by Shane Ivers - https://www.silvermansound.com

This program is non-promotional and sponsored by Sanofi. Presenter(s) were compensated and/or received an honorarium from Sanofi in connection with this program. This program does not constitute an endorsement by Sanofi of any particular organization or its programming. Additional resources and information may be available and should be investigated.

This podcast is intended for US residents only. Sanofi does not provide medical advice, diagnosis, or treatment. The health information contained herein is provided for general educational purposes only. Your healthcare professional is the best source of information regarding your health. Please consult your healthcare professional if you have any questions about your health or treatment.